Abstract
Recent studies have shown that 1,3,5-triazine (s-triazine) derivatives are potent anticancer agents. The optimized geometry and vibrational frequencies of three 1,3,5-triazine derivatives (2,4,6-triallyloxy-1,3,5-triazine, 2-chloro-4,6-dimethoxy-1,3,5-triazine and 2-butoxy-4,6-dichloro-1,3,5-triazine) have been computed using density functional theory (DFT) method. The intramolecular interactions of the title molecules have been analyzed using natural bond orbital analysis. The calculated frontier molecular orbitals have affirmed the charge transfer interaction takes place within the molecules. The quantitative structure–activity relationship (QSAR) has been analyzed for a set of ALK inhibitors and the externally validated QSAR model has theoretically predicted the inhibitory power of the title molecules. The molecular docking calculation has predicted the binding ability of the title compounds with the non-small cell lung cancer target. The molecular dynamic simulation study has validated the stability of the protein–ligand complexes. Furthermore, the drug-likeness and bioavailability of the title molecules has been assessed through in silico approach. The present investigation could help identify the 1,3,5-triazine family as an efficient anticancer drug candidate in drug discovery.
Similar content being viewed by others
Data availability
The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209–249
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F (2021) Cancer statistics for the year 2020: An overview. Int J Cancer 149(4):778–789
Cascioferro S, Parrino B, Spanò V, Carbone A, Montalbano A, Barraja P, Diana P, Cirrincione G (2017) 1,3,5-Triazines: A promising scaffold for anticancer drugs development. Eur J Med Chem 142:523–549
Cascioferro S, Parrino B, Spanò V, Carbone A, Montalbano A, Barraja P, Diana P, Cirrincione G (2017) An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. Eur J Med Chem 142:328–375
Shah DR, Modh RP, Chikhalia KH (2014) Privileged s-triazines: structure and pharmacological applications. Future Med Chem 6(4):463–477
Patel RV, Kumari P, Rajani DP, Pannecouque C, De Clercq E, Chikhalia KH (2012) Antimicrobial, anti-TB, anticancer and anti-HIV evaluation of new s-triazine-based heterocycles. Future Med Chem 4(9):1053–1065
Patil V, Noonikara-Poyil A, Joshi SD, Patil SA, Sa P, Lewis AM, Bugarin A (2020) Synthesis, molecular docking studies, and in vitro evaluation of 1,3,5-triazine derivatives as promising antimicrobial agents. J Mol Struct 1220:128687
El-Faham A, Farooq M, Almarhoon Z, Abd Alhameed R, Wadaan MAM, De la Torre BG, Albericio F (2020) Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos. Bioorg Chem 94:103397
Hamama WS, Ismail MA, Shaaban S, Zoorob HH (2012) Synthesis and biological evaluation of some new Thiazolo[3,2-a][1,3,5]triazine derivatives. Med Chem Res 21:2615–2623
Wróbel A, Kolesińska B, Frączyk J et al (2020) Synthesis and cellular effects of novel 1,3,5-triazine derivatives in DLD and Ht-29 human colon cancer cell lines. Invest New Drugs 38:990–1002
Jagadeesh Kumar G, Sriramkumar Bomma HVS, Srihari E, Shrivastava S, Naidu VGM, Srinivas K, Jayathirtha Rao V (2013) Synthesis and anticancer activity of some new s-triazine derivatives. Med Chem Res 22(12):5973–5981
Gomtsyan A (2012) Heterocycles in drugs and drug discovery. Chem Heterocycl Comp 48:7–10
Martins P, Jesus J, Santos S, Raposo LR, Roma-Rodrigues C, Baptista PV, Fernandes AR (2015) Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box. Molecules 20(9):16852–16891
Heravi MM, Zadsirjan V (2020) Prescribed drugs containing nitrogen heterocycles: an overview. RSC Adv 10:44247–44311
Liu B, Sun T, Zhou Z, Du L (2015) A systematic review on antitumor agents with 1,3,5-triazines. Med Chem 5:131–148
Sun J, Wei Q, Zhou Y, Wang J, Liu Q, Xu H (2017) A systematic analysis of FDA-approved anticancer drugs. BMC Syst Biol 11:87
Chan JK, Loizzi V, Manetta A, Berman ML (2004) Oral altretamine used as salvage therapy in recurrent ovarian cancer. Gynecol Oncol 92(1):368–371
Frei E III, Eder JP (2003) Combination chemotherapy. In: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E III (eds) Holland-Frei cancer medicine, 6th edn. BC Decker, Ontario
Maliszewski D, Drozdowska D (2022) Recent Advances in the Biological Activity of s-Triazine Core Compounds. Pharmaceuticals 15(2):221
Hu J, Zhang Y, Tang N, Lu Y, Guo P, Huang Z (2021) Discovery of novel 1, 3, 5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR. Bioorg Med Chem 32:115997
Oudah KH, Najm MA, Samir N, Serya RA, Abouzid KA (2019) Design, synthesis and molecular docking of novel pyrazolo [1, 5-a][1, 3, 5] triazine derivatives as CDK2 inhibitors. Bioorg Chem 92:103239
Yan W, Zhao Y, He J (2018) Anti-breast cancer activity of selected 1, 3, 5-triazines via modulation of EGFR-TK. Mol Med Rep 18(5):4175–4184
Singh UP, Shrivastava JK, Verma A, Bhat HR (2017) Discovery of 1,3,5-triazine-monastrol based novel EGFR-tyrosine kinase inhibitor against human lung carcinoma. Ann Oncol 28:ii10
El-Wakil MH, Khattab SN, El-Yazbi AF, El-Nikhely N, Soffar A, Khalil HH (2020) New chalcone-tethered 1, 3, 5-triazines potentiate the anticancer effect of cisplatin against human lung adenocarcinoma A549 cells by enhancing DNA damage and cell apoptosis. Bioorg Chem 105:104393
Balaha MF, El-Hamamsy MH, El-Din NAS, El-Mahdy NA (2016) Synthesis, evaluation and docking study of 1,3,5-triazine derivatives as cytotoxic agents against lung cancer. J Appl Pharm Sci 6:28–45
Iikubo K, Kondoh Y, Shimada I, Matsuya T, Mori K, Ueno Y, Okada M (2018) Discovery of N-{2-Methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl}-N′-[2-(propane-2-sulfonyl) phenyl]-1, 3, 5-triazine-2, 4-diamine (ASP3026), a Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor. Chem Pharm Bull 66(3):251–262
Chan BA, Hughes BG (2015) Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res 4(1):36–54
Frisch MJ et al (2009) Gaussian 09, Revision D. 01, Gaussian, Inc., Wallingford CT
Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98(7):5648–5652
Sundius T (2002) Scaling of ab initio force fields by MOLVIB. Vib Spectrosc 29:89–95
Glendening ED, Reed AE, Carpenter JE, Weinhold F (2003) NBO Version 3.1, Gaussian Inc., Pittsburgh
Bauernschmitt R, Ahlrichs R (1996) Treatment of electronic excitations within the adiabatic approximation of time dependent density functional theory. Chem Phys Lett 256:454–464
Dennington R, Keith T, Millam J (2009) GaussView, version 5. Semichem Inc., Shawnee Mission
de Oliveira DB, Gaudio AC (2000) BuildQSAR: a new computer program for QSAR analysis. Quant Struct Relationships 19:599–601
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461
van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701–1718
Lee SK, Chang GS, Lee IH, Chung JE, Sung KY, No KT (2004) The PreADME: PC-based program for batch predication of ADME properties. In: Proceedings of the EuroQSAR 2004, Istanbul
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717
Fridman N, Kapon M, Kaftory M (2003) 2-Chloro-4,6-dimethoxy-1,3,5-triazine. Acta Cryst C 59:o685-686
Goreshnik EA, Ciunik LZ, Gorelenko YK, Mys' kiv MG (2004) Complexation of the 2, 4, 6‐Triallyloxy‐1, 3, 5‐triazine with Copper (I, II) Chlorides. Syntheses and Crystal Structures of [CuCl2·2C3N3(OC3H5)3],[Cu7Cl8·2C3N3(OC3H5)3], and [Cu8Cl8· 2C3N3(OC3H5)3]·2C2H5OH. Z Anorg Allg Chem 630(15):2743–2748
Celik D, Kose M (2019) Triazine based Mn (II) and Mn (II)/Ln (III) complexes: Synthesis, characterization and catecholase activities. Appl Organomet Chem 33(2):e4721
Zhang M, Lu RZ, Han LN, Wei WB, Wang HB (2009) Methyl 4-butoxy-3-methoxybenzoate. Acta Cryst E 65(2):o434-434
Wheatley PJ (1955) The crystal and molecular structure of s-triazine. Acta Cryst 8(4):224–226
Sangeetha V, Govindarajan M, Kanagathara N, Marchewka MK, Gunasekaran S, Anbalagan G (2014) Vibrational, DFT, thermal and dielectric studies on 3-nitrophenol-1, 3, 5-triazine-2, 4, 6-triamine (2/1). Spectrochim Acta A Mol Biomol Spectrosc 118:1025–1037
Jin GF, Ban HS, Nakamura H, Lee JD (2018) o-Carboranylalkoxy-1, 3, 5-Triazine Derivatives: Synthesis, Characterization, X-ray Structural Studies, and Biological Activity. Molecules 23(9):2194
Alhaddad OA, Abu Al-Ola KA, Hagar M, Ahmed HA (2020) Chair-and V-Shaped of H-bonded supramolecular complexes of azophenyl nicotinate derivatives; mesomorphic and DFT molecular geometry aspects. Molecules 25(7):1510
Alves JA, Brigas AF, Johnstone RA (1996) 3-(1-naphthyloxy)-1, 2-benzisothiazole 1, 1-dioxide: Electronic effects of conjugation. Acta Crystallogr C 52(6):1576–1579
Dereli Ö, Bahçeli S, Abbas A, Naseer MM (2015) Quantum chemical investigations of a co-crystal of 1,3,5-tris(4-hydroxyphenyl)benzene and 2,4,6-trimethoxy-1,3,5-triazine. Monatsh Chem 146:1473–1484
El-Faham A, Soliman SM, Osman SM, Ghabbour HA, Siddiqui MR, Fun HK, Albericio F (2016) One pot synthesis, molecular structure and spectroscopic studies (X-ray, IR, NMR, UV–Vis) of novel 2-(4, 6-dimethoxy-1, 3, 5-triazin-2-yl) amino acid ester derivatives. Spectrochim Acta A Mol Biomol Spectrosc 159:184–198
Cinar Z, Karabacak M, Cinar M, Kurt M, Sundaraganesan N (2013) The infrared, Raman, NMR and UV spectra, ab initio calculations and spectral assignments of 2-amino-4-chloro-6-methoxypyrimidine. Spectrochim Acta A Mol Biomol Spectrosc 116:451–459
Socrates G (2004) Infrared and Raman Characteristic Group Frequencies: Tables and Charts. John Wiley & Sons, UK
Larkin PJ (2017) Infrared and Raman spectroscopy: Principles and Spectral Interpretation, 2nd edn. Elsevier, Netherlands
Yuan X, Luo K, Zhang K, He J, Zhao Y, Yu D (2016) Combinatorial Vibration-Mode Assignment for the FTIR Spectrum of Crystalline Melamine: A Strategic Approach toward Theoretical IR Vibrational Calculations of Triazine-Based Compounds. J Phys Chem A 120(38):7427–7433
Akram N, Mansha A, Premkumar R, Franklin Benial AM, Asim S, Iqbal SZ, Ali HS (2020) Spectroscopic, quantum chemical and molecular docking studies on 2,4-dimethoxy-1,3,5-triazine: a potent inhibitor of protein kinase CK2 for the development of breast cancer drug. Molecular Simulation, 46, 1340 - 1353. (2020) Spectroscopic, quantum chemical and molecular docking studies on 2,4-dimethoxy-1,3,5-triazine: a potent inhibitor of protein kinase CK2 for the development of breast cancer drug. Mole Simulation 46:1340–1353
Kanagathara N, Marchewka MK, Drozd M, Renganathan NG, Gunasekaran S, Anbalagan G (2013) Preparation, crystal structure, vibrational spectral and density functional studies of bis(4-nitrophenol)-2,4,6-triamino-1,3,5-triazine monohydrate. J Mol Struct 1049:345–354
Pekparlak A, Avci D, Atalay Y, Esmer K (2012) Theoretical Studies of Molecular Structure and Vibrational Spectra of Melaminium Salt: 2,4,6-Triamino-1,3,5-triazin-1,3-ium Tartrate Monohydrate. Arab J Sci Eng 37:171–181
Roeges NPG (1994) A Guide to the Complete Interpretation of Infrared Spectra of Organic Structures. Wiley, New York
Smith BC (2017) The C-O Bond III: Ethers by a knockout. Spectroscopy 32:22–26
Sebastian SS, Al-Tamimi AM, El-Brollosy NR, El-Emam AA, Yohannan Panicker C, Van Alsenoy C (2015) Vibrational spectroscopic (FT-IR and FT-Raman) studies, HOMO–LUMO, NBO analysis and MEP of 6-methyl-1-({[(2E)-2-methyl-3-phenyl-prop-2-en-1-yl]oxy}methyl)-1,2,3,4-tetra-hydroquinazoline-2,4-dione, a potential chemotherapeutic agent, using density functional methods. Spectrochim Acta A Mol Biomol Spectrosc 134:316–325
Dollish FR, Fateley WG, Bentley FF (1974) Characteristic Raman frequencies of organic compounds. John Wiley & Sons, New York
Joseph L, Sajan D, Chaitanya K, Isac J (2014) Molecular conformational analysis, vibrational spectra and normal coordinate analysis of trans-1,2-bis(3,5-dimethoxy phenyl)-ethene based on density functional theory calculations. Spectrochim Acta A Mol Biomol Spectrosc 122:375–386
Colthup NB, Daly LH, Wiberley SE (1975) Introduction to Infrared and Raman Spectroscopy, 2nd edn. Academic Press, New York
Smith B (1998) Infrared spectral interpretation: a systematic approach, 1st edn. CRC Press, USA
Al-Wabli RI, Govindarajan M, Almutairi MS, Attia MI (2017) A combined experimental and theoretical study on vibrational and electronic properties of (5-methoxy-1H-indol-1-yl)(5-methoxy-1H-indol-2-yl)methanone. Open Chem 15:238–246
Balachandran V, Lakshmi A, Janaki A (2011) Vibrational spectroscopic study and NBO analysis on 2-chloro-4, 6-diamino-1,3,5-triazine using DFT method. Recent Res Sci Technol 3(1):114–123
Sheikhi M, Shahab S (2016) Quantum Chemical Modeling of 1-(1, 3-Benzothiazol-2-yl)-3-(thiophene-5-carbonyl) thiourea: Molecular structure, NMR, FMO, MEP and NBO analysis based on DFT calculations. J Phy Theor Chem 13(3):277–288
Foster JP, Wienhold F (1980) Natural bond orbital analysis of near-Hartree–Fock water dimer. J Am Chem Soc 102:7211–7218
James C, Raj AA, Reghunanthan R, Jayakumar VS, Joe IH (2006) Structural conformation and vibrational spectroscopic studies of 2,6-bis(p-N, Ndimethylbenzylidene)cyclohexanone using density functional theory. J Raman Spectrosc 37:1381–1392
Brovarets’ OH, Yurenko YP, Hovorun DM (2014) Intermolecular CH··· O/N H-bonds in the biologically important pairs of natural nucleobases: a thorough quantum-chemical study. J Biomol Struct Dyn 32(6):993–1022
Reed AE, Weinstock RB, Weinhold F (1985) Natural population analysis. J Chem Phys 83:735–746
Pang F, Pulay P, Boggs JE (1982) The structure of some nitrogen heteroaromatics. J Mol Struct 88:79–89
Kerru N, Gummidi L, Maddila S, Gangu KK, Jonnalagadda SB (2020) A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules 25(8):1909
Murray JS, Sen K (1996) Molecular Electrostatic Potentials: Concepts and Applications, 1st edn. Elsevier, New York
Prabhaharan M, Prabakaran AR, Srinivasan S, Gunasekaran S (2014) Density functional theory studies on molecular structure, vibrational spectra and electronic properties of cyanuric acid. Spectrochim Acta A Mol Biomol Spectrosc 138:711–722
Miar M, Shiroudi A, Pourshamsian K, Oliaey AR, Hatamjafari F (2020) Theoretical investigations on the HOMO–LUMO gap and global reactivity descriptor studies, natural bond orbital, and nucleus-independent chemical shifts analyses of 3-phenylbenzo[d]thiazole-2(3H)-imine and its para-substituted derivatives: Solvent and substituent effects. J Chem Res 45:147–158
Tomaz CT (2017) Hydrophobic interaction chromatography, Liquid Chromatography, 2nd Edn. Elsevier (171–190)
Valadbeigi Y, Gal J (2018) On the Significance of Lone Pair/Lone Pair and Lone Pair/Bond Pair Repulsions in the Cation Affinity and Lewis Acid/Lewis Base Interactions. ACS Omega 3(9):11331–11339
Lagunin A, Stepanchikova A, Filimonov D, Poroikov V (2000) PASS: Prediction of activity spectra for biologically active substances. Bioinformatics 16:747–748
Basanagouda M, Jadhav VB, Kulkarni MV, Rao RN (2011) Computer Aided Prediction of Biological Activity Spectra: Study of Correlation between Predicted and Observed Activities for Coumarin-4-Acetic Acids. Indian J Pharm Sci 73(1):88–92
Zhang R, Xie X (2012) Tools for GPCR drug discovery. Acta Pharmacol Sin 33:372–384
Lagunin AA, Dubovskaja VI, Rudik AV, Pogodin PV, Druzhilovskiy DS, Gloriozova TA, Filimonov DA, Sastry NG, Poroikov VV (2018) CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds. PLoS ONE 13(1):e0191838
Parekh B (2015) QSAR Modeling for Drug Discovery and Development: Applications and Methodology. Int J Sci Res 4(1):329–331
Okamoto M, Kojima H, Saito N, Okabe T, Masuda Y, Furuya T, Nagano T (2011) Virtual screening and further development of novel ALK inhibitors. Bioorg Med Chem 19(10):3086–3095
Yap CW (2011) PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. J Comp Chem 32(7):1466–1474
Liu P, Long W (2009) Current mathematical methods used in QSAR/QSPR studies. Int J Mol Sci 10:1978–1998
Hadni H, Elhallaoui M (2020) 3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents. Heliyon 6(4):e03580
Bewick V, Cheek L, Ball J (2003) Statistics review 7: Correlation and regression. Crit Care 7(6):451–459
Beglari M, Goudarzi N, Shahsavani D, Arab Chamjangali M, Mozafari Z (2020) Combination of radial distribution functions as structural descriptors with ligand-receptor interaction information in the QSAR study of some 4-anilinoquinazoline derivatives as potent EGFR inhibitors. Struct Chem 31:1481–1491
Bitam S, Hamadache M, Salah H (2020) 2D QSAR studies on a series of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one as CETP inhibitors. SAR QSAR Environ Res 31(6):423–438
Pinzi L, Rastelli G (2019) Molecular Docking: Shifting Paradigms in Drug Discovery. Int J Mol Sci 20(18):44331
Yuan M, Huang LL, Chen JH, Wu J, Xu Q (2019) The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Sig Transduct Target Ther 4(1):1–4
Schrank Z, Chhabra G, Lin L, Iderzorig T, Osude C, Khan N, Kuckovic A, Singh S, Miller RJ, Puri N (2018) Current molecular-targeted therapies in NSCLC and their mechanism of resistance. Cancers 10(7):224
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235–242
Biovia DS (2015) Discovery studio visualizer, v16.1.0.15350. San Diego: Dassault Systèmes
Karpagakalyaani G, Magdaline JD, Chithambarathanu T, Aruldhas D, Anuf AR (2020) Spectroscopic (FT-IR, FT-Raman, NBO) Investigation and Molecular Docking study of a Herbicide compound Bifenox. Chem Data Collect 27:100393
Schuèttelkopf AW, Van Aalten DM (2004) PRODRG: a tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallogr D Biol Crystallogr 60(8):1355–1363
Qureshi R, Zhu M, Yan H (2021) Visualization of Protein-Drug Interactions for the Analysis of Drug Resistance in Lung Cancer. IEEE J Biomed Health Inform 25(5):1839–1848
Ahmad S, Raza S, Uddin R, Azam SS (2017) Binding mode analysis, dynamic simulation and binding free energy calculations of the MurF ligase from Acinetobacter baumannii. J Mol Graph Model 77:72–85
Zhao YH, Le J, Abraham MH, Hersey A, Eddershaw PJ, Luscombe CN, Boutina D, Beck G, Sherborne B, Cooper I, Platts JA (2001) Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure–activity relationship (QSAR) with the Abraham descriptors. J Pharm Sci 90(6):749–784
Mishra S, Dahima R (2019) In vitro ADME studies of TUG-891, a GPR-120 inhibitor using SWISS ADME predictor. J Drug Deliv Ther 9(2-s):366–369
Nanayakkara AK, Follit CA, Chen G, Williams NS, Vogel PD, Wise JG (2018) Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells. Sci Rep 8(1):1–8
Lipinski CA (2004) Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337–341
Rothwell JA, Day AJ, Morgan MR (2005) Experimental determination of octanol− water partition coefficients of quercetin and related flavonoids. J Agric Food Chem 53(11):4355–4360
Nabati M, Bodaghi-Namileh V (2020) Evaluation of Medicinal Effects of Isoxazole Ring Isosteres on Zonisamide for Autism Treatment by Binding to Potassium Voltage-Gated Channel Subfamily D Member 2 (Kv 4.2). Adv J Chem A 3(4):462–472
Begum AR, Begum S, Prasad KV, Bharathi K (2017) In silico studies on functionalized azaglycine derivatives containing 2, 4-thiazolidinedione scaffold on multiple targets. Int J Pharm Pharm Sci 9(8):209–215
Funding
This work was supported by CSIR-JRF (CSIR File. No: 08/1278(0001/2019-EMR-I). Author Kirishnamaline Gomathishankkar has received research support from CSIR, New Delhi, India.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Kirishnamaline Gomathishankkar. The first draft of the manuscript was written by Kirishnamaline Gomathishankkar, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gomathishankkar, K., Joseph Yesudian, D.M., Thiraviam, C. et al. Quantum chemical evaluation, QSAR analysis, molecular docking and dynamics investigation of s-triazine derivatives as potential anticancer agents. Struct Chem 33, 2083–2113 (2022). https://doi.org/10.1007/s11224-022-01968-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11224-022-01968-2